ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683517 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683517; 2) Community: the network communities that were significantly associated with the response to NSC 683517; 3) Molecule: the relationships between components within communities and NSC 683517; 4) MDR: the compounds that were significantly associated with the NSC 683517.

NSC Compound Enrichment Correlation
NSC 674955 Null 0.0135588245836371 0.10495946
NSC 682765 5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 2-(4-chlorophenyl)-4-phenyl- 0.0135588245836371 -0.029806831
NSC 721081 Null 0.0135588245836371 0.41543333
NSC 728115 N4-(4-chlorophenyl)-4-quinazolinamine 4-chlorophenyl(4-quinazolinyl)amine hydrochloride 0.0135588245836371 -0.16623596
NSC 740642 Null 0.0135588245836371 0.15186117
NSC 746608 Null 0.0135588245836371 0.042302792
NSC 92909 ANTINEOPLASTIC-92909 0.0135588245836371 0.38841862
NSC 93427 Null 0.0135588245836371 0.09279928
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0137891122538509 0.62353339
NSC 208885 Null 0.0137891122538509 0.56299638
Total:44  Current:13    [First] [Prev] [Next] [Last]